LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)

Q: What does CUSIP G9845F208 represent in this 13F holders report?

CUSIP G9845F208 is the security identifier for LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share used to aggregate holder disclosures.

Q: How many institutions held LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share in Q4 2024?

6 institutional investors reported LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: G9845F208

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / Ordinary Shares, par value $0.0002 per share
Shares outstanding: 41,218,298
Total 13F shares: 388,604
Share change: +388,604
Total reported value: $1,342,686
Price per share: $3.45
Number of holders: 6
Value change: +$1,342,686
Number of buys: 6

Quarterly Holders Quick Answers

What is CUSIP G9845F208?
CUSIP G9845F208 identifies LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025

Recent filing periods for CUSIP G9845F208:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Top shareholders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	— class O/S missing	1,165,071	$802,734	—	30 Sep 2024	13F
HHLR ADVISORS, LTD.	13F	Company	— class O/S missing	751,790	$512,721	—	30 Sep 2024	13F
FIL Ltd	13F	Company	— class O/S missing	615,475	$424,062	—	30 Sep 2024	13F
SUPERSTRING CAPITAL MANAGEMENT LP	13F	Company	— class O/S missing	307,920	$212,157	—	30 Sep 2024	13F
BARCLAYS PLC	13F	Company	— class O/S missing	247,575	$168,846	—	30 Sep 2024	13F
BANK OF MONTREAL /CAN/	13F	Company	— class O/S missing	93,808	$75,515	—	30 Sep 2024	13F
UBS Group AG	13F	Company	— class O/S missing	49,418	$33,703	—	30 Sep 2024	13F

Institutional Holders of LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) as of Q4 2024

As of 31 Dec 2024, LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 388,604 shares. The largest 6 holders included ORBIMED ADVISORS LLC, FMR LLC, HHLR ADVISORS, LTD., SUPERSTRING CAPITAL MANAGEMENT LP, BARCLAYS PLC, and UBS Group AG. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2024 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2024 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.